针对雄激素受体及其结合变体的治疗方法在乳腺癌中
Amy H Tien1, Marianne D Sadar1,2
1Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 1L3, Canada.
International journal of molecular sciences
|February 10, 2024
概括
向雄激素受体 (AR) 提供了新的乳腺癌治疗选择,特别是对于耐药病例. 了解AR状态并将其与其他疗法向,可能会改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 乳腺癌是全球死亡的主要原因之一.
- 乳腺癌中的内分泌抵抗限制了治疗选择,并增加了疾病的攻击性.
- 向疗法,包括调节核受体的疗法,比传统化疗更有前途.
研究的目的:
- 突出雄激素受体 (AR) 作为乳腺癌治疗标和预后生物标记物的新兴作用.
- 探索AR拼接变种在治疗耐药性的意义.
- 讨论针对AR的潜力,与其他受体结合,以改善乳腺癌管理.
主要方法:
- 关于乳腺癌中核受体信号传导的当前文献的综述.
- 对雌激素受体 (ER),孕激素受体和人体表皮生长因子受体2与AR结合作用的分析.
- 检查正在进行的临床试验,调查AR向疗法.
主要成果:
- 雄激素受体 (AR) 越来越被认为是乳腺癌的关键因素,特别是在内分泌耐药的形式.
- 构成性活跃的截断AR拼接变种与治疗耐药性有关.
- 针对AR,以及ER,孕激素受体或HER2状态,为新型治疗组合提供了一个有前途的战略.
结论:
- 通过激活或抑制调节雄激素受体 (AR) 功能,为乳腺癌治疗提供了潜在的新途径,特别是耐药亚型.
- 确定核受体状态对于分层患者和优化组合疗法至关重要.
- 进一步的临床试验对于验证乳腺癌治疗中的AR向策略至关重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


